Journals from ACC

• Inflammation, Aging, and Cardiovascular Disease This review discusses recent advances regarding "inflamm-aging"; that is, age-dependent activation of inflammation and the pathways by which it influences the onset of cardiovascular disease.
  Journal of the American College of Cardiology, May 18, 2022
• Renal Compression in HF: The Renal Tamponade Hypothesis A new hypothesis suggests that central venous pressure increases and renal encapsulation may be a factor in renal damage due to heart failure, and a novel target for treatment.
  JACC: Heart Failure, May 18, 2022
• Predicting Left Main Coronary Artery Stenosis Without Imaging A recent study aimed to help identify patients with highly probable vs. low risk of left main coronary artery disease using clinical and noninvasive functional parameters. Is it feasible?
  Journal of the American College of Cardiology, April 08, 2022
• Interventions for Frailty Among Older Adults With CVD Review the various definitions of frailty, how frailty can be measured, and interventions to prevent, reverse, or slow the progression of frailty in patients with cardiovascular disease.
  Journal of the American College of Cardiology, March 25, 2022
• Systematic Review: Pharmacological Treatment of HFrEF This study aimed to estimate and compare the aggregate treatment benefit of pharmacological therapy for HFrEF. Which combination of therapies was most effective in improving outcomes?
  JACC: Heart Failure, March 21, 2022
• GI Injury by Aspirin or Clopidogrel Monotherapy vs. DAPT A new study explores the mechanisms of mucosal injury and GI bleeding with differing antiplatelet regimens in patients undergoing PCI.
  Journal of the American College of Cardiology, March 11, 2022
• Coronary Atherosclerotic Plaque Regression This review focuses on novel treatment strategies that may induce atherosclerotic plaque regression, highlighting imaging modalities that can assess changes in plaque volumes and composition.
  Journal of the American College of Cardiology, February 25, 2022
• Cost and Value in Heart Failure Clinical Guidance Documents Are contemporary heart failure clinical practice guidelines and appropriate use criteria lacking in cost/value statements?
  JACC: Heart Failure, February 25, 2022
• Early Discharge After STEMI: The Days Are Getting Shorter! A new study demonstrates that it is safe to discharge very low-risk patients 24 hours after primary PCI for ST-segment elevation myocardial infarction.
  Journal of the American College of Cardiology, January 31, 2022
• The Other Ventricle With Left Ventricular Assist Devices Left ventricular assist devices are an integral part of management of advanced heart failure, but should we be paying more attention to right ventricular function in patients with LVADs?
  Journal of the American College of Cardiology, January 24, 2022
• Chloride in Heart Failure: The Neglected Electrolyte What do we know about the role of chloride in the pathophysiology of heart failure? This review aims to elucidate the complex interplay of serum chloride and other electrolytes such as sodium in HF.
  JACC: Heart Failure, January 24, 2022
• Dapagliflozin in Patients With CKD, With and Without HF Heart failure is common in patients with chronic kidney disease. Might the SGLT-2 inhibitor dapagliflozin reduce the risk of kidney failure and cardiovascular death in these patients?
  JACC: Heart Failure, January 03, 2022
• Cost-Effectiveness of Lipid-Lowering Treatments in Young Adults Is it cost-effective to initiate statin therapy in adults under age 40 with elevated LDL-C?
  Journal of the American College of Cardiology, January 03, 2022
• Finding the Right Age for CAC Testing: How Low Should You Go? Should routine CAC testing for ASCVD risk stratification be extended to younger adults? This commentary weighs the risks and benefits.
  Journal of the American College of Cardiology, December 13, 2021
• Treatment Thresholds and ASCVD Risk A new study reveals benefit to high-intensive statin therapy among very-high-risk patients, even if their baseline LDL-C levels are low.
  Journal of the American College of Cardiology, December 06, 2021
• Health Care Equity Cannot Afford Further Delays In this commentary, the author makes the case for universal health care coverage and equitable reimbursement across payers to insure equitable health care across all demographics.
  JACC: Heart Failure, December 06, 2021
• Approach to Weaning Temporary Mechanical Circulatory Support When should percutaneous temporary mechanical circulatory support be used in patients with cardiogenic shock, and what is the optimal approach to device weaning or explant?
  JACC: Heart Failure, November 29, 2021
• That Myalgia of Yours Is Not From Statin Intolerance A new trial evaluating the tolerability of statins suggests that the bulk of statin-related myalgias are not due to the drug at all.
  Journal of the American College of Cardiology, November 29, 2021
• Chronic Fatigue Syndrome and Cardiovascular Disease This review details cardiovascular changes which may occur in patients with chronic fatigue syndrome. How might these changes contribute to the symptoms and debilitation associated with this disorder?
  Journal of the American College of Cardiology, November 22, 2021
• Plant Polyphenols Lignans and Cardiovascular Disease Dietary lignans and their impact on coronary heart disease are the focus of a new study, contributing further evidence of an association between polyphenol intake and chronic disease.
  Journal of the American College of Cardiology, October 13, 2021